Development of TRPM8 Antagonists to Treat Chronic Pain and Migraine

A review. Development of pharmaceutical antagonists of transient receptor potential melastatin 8 (TRPM8) have been pursued for the treatment of chronic pain and migraine. This review focuses on the current state of this progress.

Detalles Bibliográficos
Autores principales: Weyer, Andy D., Lehto, Sonya G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490394/
https://www.ncbi.nlm.nih.gov/pubmed/28358322
http://dx.doi.org/10.3390/ph10020037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490394/
https://www.ncbi.nlm.nih.gov/pubmed/28358322
http://dx.doi.org/10.3390/ph10020037

Ejemplares similares